Syremis Therapeutics
Tel Aviv, Tel Aviv District, Israel · Biotechnology, Health Care
Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health. The company’s neuropsychiatric pipeline is rooted in emerging and clinically validated mechanisms, including muscarinic M1/M4 agonism and next-generation NMDA antagonism.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Tel Aviv, Tel Aviv District, Israel
- Employees
- 18
- Industries
- Biotechnology, Health Care
- Status
- Private
- Website
- syremis.com
- Company page
Recent activity at Syremis Therapeutics
About Syremis Therapeutics: questions and answers
What does Syremis Therapeutics do?
Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health. The company’s neuropsychiatric pipeline is rooted in emerging and clinically validated mechanisms, including muscarinic M1/M4 agonism and next-generation NMDA antagonism.
Where is Syremis Therapeutics headquartered?
Syremis Therapeutics is headquartered in Tel Aviv, Tel Aviv District, Israel.
How many employees does Syremis Therapeutics have?
Syremis Therapeutics has about 18 employees.
What is the latest news on Syremis Therapeutics?
On Jun 16, 2026, Syremis Therapeutics Appoints Dr. Aaron Koenig as Chief Medical Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy